Selection procedure reference: EMA/TR/11370
Deadline for applications: 06 May 2026 23:59 CET
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
This traineeship opportunity is now open for applications until 06 May 2026 23:59 CET, with an intake on 1 October 2026.
About the traineeship programme
The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master's students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description
We are looking for a trainee in the Pharmaceutical Quality Office.
Specific objectives and projects
Context
As environmental sustainability becomes increasingly important, the pharmaceutical sector faces growing expectations to design, develop, manufacture and manage medicinal products with sustainability in mind. The EU and the European medicines regulatory network have identified environmental sustainability as a key objective in their recent strategy documents.
The European Medicines Agency supports innovation aimed at implementing more sustainable manufacturing approaches through the work of the Quality Innovation Group and the development of guidance in areas such as F-gas replacements, continuous manufacturing and other quality aspects (e.g. packaging) that may have an impact on environmental sustainability.
Project tasks
map and analyse green manufacturing approaches described in marketing authorisation applications (MAA) and lifecycle submissions;
identify trends and regulatory challenges that applicants face in MAA and lifecycle submissions related to green manufacturing;
identify areas where future guidance may be needed to support the implementation of sustainable manufacturing approaches, and contribute proposals for consideration within the BWP, QWP and QIG work planning;
contribute to the preparation of Q&As, where relevant.
Learning outcomes
By the end of the traineeship, the trainee will:
develop knowledge of the regulatory framework supporting innovation in the development and manufacture of human medicines;
gain insight into EU legislation related to environmental sustainability;
gain practical experience working with the Quality Innovation Group and the European regulatory network and expert groups;
gain insight into how marketing authorisation applications are evaluated at EMA.
Eligibility criteria
To be eligible for consideration for this placement, you are required to:
- enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
- possess a university degree in pharmacy, life sciences or engineering (minimum of three years or more) that must have been obtained between 6 May 2025 and 6 May 2026 or be a university student on an Erasmus + or a similar programme or a PhD student or a Master's student with a previous fully finished degree in the areas mentioned before.
- a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages
For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.
Additional skills
In addition to the eligibility criteria, you will have:
- Good knowledge of pharmaceutical quality and manufacturing
- An interest in environmental sustainability
- Analytical skills
- Collaboration skills
Behavioural Competencies
You will demonstrate the following behavioural competencies:
- Communication skills
- Interpersonal skills
- Working with others
- Adaptability
- Research and analytical skills
- Learning and development
Conditions of traineeship
The traineeship is offered for 10 months (1 October 2026 – 31 July 2027) and takes place at the Agency’s premises in Amsterdam with possibility for teleworking up to 40% of working time from The Netherlands and occasional teleworking from outside The Netherlands. Traineeships are offered for either full-time or part-time (80% or 50%) if combined with university studies.
The Agency pays a monthly stipend of €2,049.77 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining the Agency.
Each trainee will have a mentor at the Agency who will guide the trainee through the programme.
The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.
Expected selection timelines
| Deadline for applications |
06 May 2026 23:59 CET |
| Assessments (remote) |
From mid-June 2026 to mid-July 2026 |
| Decision and offers |
By end of July 2026 |
| Placement start |
1 October 2026 |
______________________________________________________________________________________________________
Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands
Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu
© European Medicines Agency, 2024. Reproduction is authorised provided the source is acknowledged.
